Skip to content
10-Q

Quarterly Report

HELIX BIOMEDIX INC

0001437749-12-004808

← back to feed
Filed
May 10, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · Apr 30, 2012 49.72M sh
Shares Diluted Q1 2012 · Mar 31, 2012 49.72M sh
Shares Diluted Q1 2012 · Mar 31, 2011 49.72M sh
Capex Q1 2012 · Mar 31, 2012 $0
Capex Q1 2012 · Mar 31, 2011 $20.66K
Operating Cash Flow Q1 2012 · Mar 31, 2012 −$525.41K
Operating Cash Flow Q1 2012 · Mar 31, 2011 −$752.88K
Cash And Equivalents Q1 2012 · Mar 31, 2012 $1.16M
Cash And Equivalents Q1 2012 · Dec 31, 2011 $1.69M
Cash And Equivalents Q1 2012 · Mar 31, 2011 $3.27M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $4.04M
Stockholders Equity Q1 2012 · Mar 31, 2012 $2.54M
Stockholders Equity Q1 2012 · Dec 31, 2011 $2.54M
Stockholders Equity Q1 2012 · Dec 31, 2010 $4.87M
Current Liabilities Q1 2012 · Mar 31, 2012 $485.58K
Current Liabilities Q1 2012 · Dec 31, 2011 $410.64K
Total Liabilities Q1 2012 · Mar 31, 2012 $511.91K
Total Liabilities Q1 2012 · Dec 31, 2011 $439.3K
Current Assets Q1 2012 · Mar 31, 2012 $2.43M
Current Assets Q1 2012 · Dec 31, 2011 $2.56M
Total Assets Q1 2012 · Mar 31, 2012 $3.05M
Total Assets Q1 2012 · Dec 31, 2011 $2.97M
Eps Diluted Q1 2012 · Mar 31, 2012 −$0.01
Eps Diluted Q1 2012 · Mar 31, 2011 −$0.01
Sga Expense Q1 2012 · Mar 31, 2012 $384.58K
Sga Expense Q1 2012 · Mar 31, 2011 $341.79K
Rd Expense Q1 2012 · Mar 31, 2012 $87.09K
Rd Expense Q1 2012 · Mar 31, 2011 $225.16K
Net Income Q1 2012 · Mar 31, 2012 −$581.84K
Net Income Q1 2012 · Dec 31, 2011 −$2.49M
Net Income Q1 2012 · Mar 31, 2011 −$709.73K
Operating Income Q1 2012 · Mar 31, 2012 −$546.19K
Operating Income Q1 2012 · Mar 31, 2011 −$726.65K
Gross Profit Q1 2012 · Mar 31, 2012 $470.89K
Gross Profit Q1 2012 · Mar 31, 2011 $236.8K
Cost Of Revenue Q1 2012 · Mar 31, 2012 $209.53K
Cost Of Revenue Q1 2012 · Mar 31, 2011 $120.83K
Revenue Q1 2012 · Mar 31, 2012 $680.42K
Revenue Q1 2012 · Mar 31, 2011 $357.63K